Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47.6M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
22.5M
-
Shares change
-
-8.19M
-
Total reported value, excl. options
-
$4.3M
-
Value change
-
-$19.8M
-
Put/Call ratio
-
0.84
-
Number of buys
-
16
-
Number of sells
-
-19
-
Price
-
$0.19
Significant Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q3 2025
52 filings reported holding EPIX - ESSA Pharma Inc. - Common Shares, no par value per share as of Q3 2025.
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.5M shares
of 47.6M outstanding shares and own 47.31% of the company stock.
Largest 10 shareholders include BVF INC/IL (11.7M shares), Soleus Capital Management, L.P. (4.36M shares), MORGAN STANLEY (1.9M shares), Pfizer Inc (1.68M shares), BANK OF AMERICA CORP /DE/ (592K shares), LMR Partners LLP (541K shares), Shay Capital LLC (537K shares), TWO SIGMA INVESTMENTS, LP (336K shares), TWO SIGMA ADVISERS, LP (215K shares), and CITADEL ADVISORS LLC (144K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.